Search results
Prostate cancer study reveals molecular switch linked to lineage plasticity, therapy resistance
Medical Xpress· 1 day agoTwo genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.
Does Diet Affect Progression Risk After Prostate Cancer?
Medscape· 7 days agoAfter diagnosis and treatment of prostate cancer, men who predominantly consumed plant-based diets...
Cheap Drug Eases Hot Flashes in Men With Prostate Cancer
MedPage Today· 4 days agoA widely available anticholinergic significantly improved hot flash symptoms in men taking androgen...
Chromatin openness sheds new light on prostate cancer plasticity
Medical Xpress· 3 days agoTreatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. A recent study ...
Breakthrough as simple at-home saliva test could ‘turn tide’ on prostate cancer
Daily Express· 6 days agoA pioneering genetic test is set to “turn the tide on prostate cancer”, saving thousands of lives...
Orgovyx dosage: Form, strength, how to take, and more
Medical News Today· 1 day agoOrgovyx (relugolix) is a brand-name drug prescribed for advanced prostate cancer in adults. Orgovyx...
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 17 hours agoITM, short for Isotope Technologies Munich, has advanced a radiopharmaceutical drug for a type of...
Prostate cancer? Ptooey! Saliva test detects aggressive tumors in study
FierceBiotech· 3 days agoA clinical study found an at-home test based on the DNA found in spit samples could detect cases of ...
Implementing pharmacogenomic and genetic testing into prostate cancer clinics
Medical Xpress· 6 days agoProstate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC ...
Radiopharma-focused Telix heats up IPO summer market with $200M offering
FierceBiotech· 1 day agoAustralian radiopharmaceuticals biotech Telix Pharmaceuticals is targeting a $200 million initial...